Atlas Trials

A Varegacestat Hepatic Impairment Study

Clinical trial NCT06841315 · COMPLETED

Trial details

NCT number
NCT06841315
Sponsor
Immunome, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy VolunteerHepatic Impairment (HI)
Start date
2025-03-07
Primary completion
2025-11-05
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.